☰

Rohini Mehta, Ph.D. - Publications

Affiliations: 
2013 Biosciences George Mason University, Washington, DC 
Area:
Molecular Biology, Physiology Biology
Tree Info Grants Similar researchers PubMed Report error

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Price JK, Estep JM, Escheik C, Austin P, Mehta R, Gerber L, Younossi ZM. Su1587 ACTIVITY SELF-REPORT DERIVED CALCULATION LINKS FATIGUE AND PERCEIVED EXERTION TO PHYSICAL PERFORMANCE CAPACITY BUT NOT METABOLIC MEASURES Gastroenterology. 158: S-1348. DOI: 10.1016/S0016-5085(20)34040-3  0.631
2019 Gerber LH, Weinstein AA, Mehta R, Younossi ZM. Importance of fatigue and its measurement in chronic liver disease. World Journal of Gastroenterology. 25: 3669-3683. PMID 31391765 DOI: 10.3748/Wjg.V25.I28.3669  0.426
2019 Estep M, Mehta R, Bratthauer G, Alaparthi L, Monge F, Ali S, Abdelatif D, Younoszai Z, Stepanova M, Goodman ZD, Younossi ZM. Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis. Bmc Gastroenterology. 19: 27. PMID 30744560 DOI: 10.1186/S12876-019-0951-Y  0.487
2019 Mehta R, Paik J, Felix SC, Allawi H, Schneider I, Lam BP, Pham H, Younossi ZM. Su1553 – Oral and Gut Microbiome Diversity in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Fibrosis Gastroenterology. 156: S-1295-S-1296. DOI: 10.1016/S0016-5085(19)40247-3  0.43
2018 Mehta R, Shaw G, Masschelin P, Felix S, Otgonsuren M, Baranova A, Goodman Z, Younossi Z. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). Plos One. 13: e0199294. PMID 29928018 DOI: 10.1371/Journal.Pone.0199294  0.622
2018 Estep JM, Mehta R, Felix SC, Nguyen J, Epler P, Singh S, Birerdinc A, Goodman Z, Younossi ZM. Sa1471 - Integrin Beta 3 Subunit Leu48->Pro Polymorphism is Positively Associated with Pericellular Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 154: S-1124. DOI: 10.1016/S0016-5085(18)33738-7  0.792
2018 Mehta R, Estep JM, Felix SC, Allawi H, Lam BP, Paik J, Schneider I, Younossi ZM. 987 - Microbiome Diversity and Presence of Extracellular DNA in Stool Samples of Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Hepatic Fibrosis Gastroenterology. 154: S-1111. DOI: 10.1016/S0016-5085(18)33696-5  0.748
2018 Mehta R, Sproelich M, Bondurant S, Estep JM, Abdul-Al H, Paik J, Felix SC, Younossi ZM. 516 - Mitochondrial Dna Content is Associated with Advanced Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 154: S-1096. DOI: 10.1016/S0016-5085(18)33650-3  0.745
2018 Rodriguez E, Tavakolian K, Mehta R, Paik J, Rafiq N, Goodman Z, Chandhoke V, Birerdinc A, Younossi ZM. Tu1514 - Serum Cytokines and their Associations with Histological Features of Non-Alcoholic Steatohepatitis (NASH) Gastroenterology. 154: S-949. DOI: 10.1016/S0016-5085(18)33199-8  0.663
2018 Rodriguez E, Tavakolian K, Mehta R, Paik J, Goodman Z, Chandhoke V, Birerdinc A, Younossi ZM. Sa1878 - Local and Exogenous Cytokines Contribute to the Visceral Adipose (VAT) Derived Inflammatory Cascade Observed in Obese Non-Alcoholic Liver Disease (NAFLD) Subjects Gastroenterology. 154: S-429. DOI: 10.1016/S0016-5085(18)31701-3  0.749
2017 Zolotarenko A, Chekalin E, Mehta R, Baranova A, Tatarinova TV, Bruskin S. Identification of Transcriptional Regulators of Psoriasis from RNA-Seq Experiments. Methods in Molecular Biology (Clifton, N.J.). 1613: 355-370. PMID 28849568 DOI: 10.1007/978-1-4939-7027-8_14  0.496
2017 Birerdinc A, Karrar A, Elsheikh E, Mehta R, Estep JM, Pierobon M, Stepanova M, Druker L, Jeiran K, Hodge A, Monge F, Alaparthi LP, Abdelatif D, Goodman Z, Petricoin E, et al. The Molecular Crosstalk Between Hepatic Tissue and Visceral Adipose Tissue in Patients with Obesity-Related Nonalcoholic Fatty Liver Disease (NAFLD): The Interactions between Inflammation and Immune Activation Gastroenterology. 152: S1159. DOI: 10.1016/S0016-5085(17)33882-9  0.805
2017 Shaw G, Mehta R, Otgonsuren M, Birerdinc A, Chandhoke V, Younossi ZM. Haplotype Analysis of the Rage Gene: Identification of a Haplotype Marker for Non-Alcoholic Steatohepatitis (NASH) Gastroenterology. 152: S1065. DOI: 10.1016/S0016-5085(17)33596-5  0.676
2017 Estep JM, Golabi P, Mehta R, Lam BP, Birerdinc A, Felix S, Younoszai Z, Jeffers T, Cable R, Pham H, Afendy M, Cooper J, Gerber L, Younossi ZM. Decreased Circulating Kynurenine is Associated with Post-Treatment Resolution of Fatigue as Measured by the FACIT-F in CH-C Patients Gastroenterology. 152: S903. DOI: 10.1016/S0016-5085(17)33087-1  0.715
2016 Zolotarenko A, Chekalin E, Mesentsev A, Kiseleva L, Gribanova E, Mehta R, Baranova A, Tatarinova TV, Piruzian ES, Bruskin S. Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis. Experimental & Molecular Medicine. 48: e268. PMID 27811935 DOI: 10.1038/Emm.2016.97  0.506
2016 Mehta R, Jeiran K, Koenig AB, Otgonsuren M, Goodman Z, Baranova A, Younossi Z. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH). Bmc Medical Genetics. 17: 63. PMID 27596100 DOI: 10.1186/S12881-016-0324-0  0.664
2016 Mehta R, Otgonsuren M, Younoszai Z, Allawi H, Raybuck B, Younossi Z. Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease. Bmj Open Gastroenterology. 3: e000096. PMID 27493762 DOI: 10.1136/Bmjgast-2016-000096  0.435
2016 Younossi ZM, Rodriguez E, Doyle K, Tavakolian K, Mehta R, Druker L, Birerdinc A, Goodman Z. Protein Levels in the Visceral Adipose Tissue (VAT) of Morbidly Obese Subjects with Non-alcoholic Fatty Liver Disease (NALFD) Suggests Pro-inflammatory and Pro-fibrotic Signaling American Journal of Gastroenterology. 111: S383-S384. DOI: 10.14309/00000434-201610001-00876  0.746
2016 Mehta R, Birerdinc A, Doyle K, Keaton M, Srishord I, McLaughlin L, Jeffers T, Felix S, Goodman Z, Younossi ZM. Sa1665 Receptors for Advanced Glycation Endproducts and Markers of Systemic Inflammation in Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 150: S1090. DOI: 10.1016/S0016-5085(16)33679-4  0.713
2016 Estep JM, Mehta R, Frost S, Sayiner M, Jeffers T, Younoszai Z, Lao I, Goodman Z, Younossi ZM. Mo1525 Minor Alleles for PNPLA3 and TM6SF2 Inadequate for Diagnosis of Non-Alcoholic Steatohepatitis in a Morbidly Obese Population Gastroenterology. 150: S715. DOI: 10.1016/S0016-5085(16)32436-2  0.733
2015 Koenig A, Mehta R, Monge F, Goodman ZD, Younossi ZM. PNPLA3 (I148M) Variant Is Not Associated with LC3 Mediated Autophagy in Non-alcoholic Fatty Liver Disease (NAFLD): 2150 The American Journal of Gastroenterology. 110. DOI: 10.14309/00000434-201510001-02150  0.509
2015 Mehta R, Koenig AB, Younoszai Z, Younossi ZM. Su1808 Effects of Farnesoid X Receptor (FXR) Agonist on Expression of Genes That Regulate Fatty Acid Metabolism in Hepatocyte Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 148: S-1056. DOI: 10.1016/S0016-5085(15)33605-2  0.479
2015 Jeiran K, Mehta R, Otgonsuren M, Koenig AB, Goodman ZD, Baranova A, Younossi ZM. Su1797 Mitochondrial DNA Polymorphisms and Protection Against Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 148: S-1053. DOI: 10.1016/S0016-5085(15)33594-0  0.638
2014 Mehta R, Neupane A, Wang L, Goodman Z, Baranova A, Younossi ZM. Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects. Bmc Gastroenterology. 14: 208. PMID 25512222 DOI: 10.1186/S12876-014-0208-8  0.706
2014 Mehta R, Birerdinc A, Wang L, Younoszai Z, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease. Bmc Gastroenterology. 14: 72. PMID 24716593 DOI: 10.1186/1471-230X-14-72  0.788
2014 Glebova K, Reznik ON, Reznik AO, Mehta R, Galkin A, Baranova A, Skoblov M. siRNA technology in kidney transplantation: current status and future potential. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 28: 345-61. PMID 24573958 DOI: 10.1007/S40259-014-0087-0  0.463
2014 Mehta R, Birerdinc A, Younossi ZM. Host genetic variants in obesity-related nonalcoholic fatty liver disease. Clinics in Liver Disease. 18: 249-67. PMID 24274878 DOI: 10.1016/J.Cld.2013.09.017  0.683
2014 Younossi ZM, Reyes MJ, Mishra A, Mehta R, Henry L. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. Alimentary Pharmacology & Therapeutics. 39: 3-14. PMID 24206433 DOI: 10.1111/Apt.12543  0.446
2014 Doyle K, Keaton M, Wang L, Mehta R, Abawi M, Younoszai Z, Jeffers T, Elarainy HA, Moazez AH, Birerdinc A, Baranova A, Younossi ZM. Tu2019 Role of Vitamin D in the Inflammatory Response of Morbidly Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 146: S-900. DOI: 10.1016/S0016-5085(14)63272-8  0.652
2014 Keaton M, Doyle K, Wang L, Mehta R, Younoszai Z, Birerdinc A, Elarainy HA, Baranova A, Younossi ZM. Mo1776 Potential Factors Involved in the Differentiation of Bat From Wat in Morbidly Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 146: S-657. DOI: 10.1016/S0016-5085(14)62392-1  0.723
2014 Estep JM, Greer A, Mehta R, Elsheikh E, Jeffers T, Goodman ZD, Elarainy HA, Moazez AH, Younossi ZM. Sa1357 Histologic NASH Is Associated Lack of Improvement of Metabolic Conditions Post Bariatric Surgery Gastroenterology. 146: S-271. DOI: 10.1016/S0016-5085(14)60959-8  0.648
2013 Mehta R, Birerdinc A, Younossi Z. Quo vadis: from oxidative stress to gamma-glutamyltransferase upregulation to mortality. Journal of Clinical and Experimental Hepatology. 3: 2-3. PMID 25755465 DOI: 10.1016/J.Jceh.2013.02.004  0.636
2013 Baranova A, Tran TP, Afendy A, Wang L, Shamsaddini A, Mehta R, Chandhoke V, Birerdinc A, Younossi ZM. Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). Journal of Translational Medicine. 11: 133. PMID 23721173 DOI: 10.1186/1479-5876-11-133  0.785
2013 Mehta R, Birerdinc A, Neupane A, Shamsaddini A, Afendy A, Elariny H, Chandhoke V, Baranova A, Younossi ZM. Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD. Mediators of Inflammation. 2013: 684237. PMID 23661906 DOI: 10.1155/2013/684237  0.758
2013 Doyle K, Birerdinc A, Wang L, Mehta R, Koob C, Sok S, Younoszai Z, Chandhoke V, Baranova A, Younossi Z. TGF-Beta-Guided Inflammatory Signaling Originating in Visceral Adipose Tissue Is Intrinsically Involved in the Etiology of Depression in Obese Patients with Non-alcoholic Fatty Liver Disease (NAFLD) American Journal of Gastroenterology. 108: S118. DOI: 10.14309/00000434-201310001-00392  0.779
2013 Birerdinc A, Doyle K, Wang L, Dadkhah E, Mehta R, Afendy A, Baranova A, Goodman Z, Younossi ZM. Mo1047 The Adipocyte-Derived PRO-Inflammatory and Fibrogenic Factors Differentially Influence Individual Pathogenetic Components of Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 144: S-1021-S-1022. DOI: 10.1016/S0016-5085(13)63793-2  0.767
2013 Doyle K, Birerdinc A, Wang L, Mehta R, Younoszai Z, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Tu2041 The Levels of TGFβ1 Production in Adipose Indicate the Complexity of the Relationship Between Depression and Anxiety Disorders in Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 144: S-910-S-911. DOI: 10.1016/S0016-5085(13)63397-1  0.768
2013 Birerdinc A, Mehta R, Doyle K, Wang L, Keskin T, Younoszai Z, Baranova A, Elariny HA, Moazzez AH, Younossi ZM. Tu1747 MRNAs for Ucp1 and PRDM16 Are Detectable in Visceral Adipose of Obese Subjects Indicating Therapeutic Trans-Differentiation Potential Gastroenterology. 144: S-836. DOI: 10.1016/S0016-5085(13)63110-8  0.714
2013 Mehta R, Keaton M, Wang L, Birerdinc A, Doyle K, Baranova A, Moazzez AH, Elariny HA, Younossi ZM. 396 The Balance of T-Lymphocyte Specifying Transcription Factors and the Cytokine Expression in Obese Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 144: S-77. DOI: 10.1016/S0016-5085(13)60281-4  0.786
2012 Mehta R, Younossi ZM. Natural history of nonalcoholic fatty liver disease. Clinical Liver Disease. 1: 112-113. PMID 31186863 DOI: 10.1002/Cld.27  0.439
2012 Birerdinc A, Mehta R, Alhussain R, Afendi A, Chandhoke V, Younossi Z, Baranova A. [Selection of reliable reference genes for qRT-PCR analysis in human non-cancerous gastric tissue]. Molekuliarnaia Biologiia. 46: 166-75. PMID 22642115 DOI: 10.1134/S0026893312010049  0.705
2012 Mehta R, Baranova A, Birerdinc A. Do-It-Yourself device for recovery of cryopreserved samples accidentally dropped into cryogenic storage tanks. Journal of Visualized Experiments : Jove. e3903. PMID 22617806 DOI: 10.3791/3903  0.645
2012 Karrar A, Mehta R, Hariharan S, Lee K, Stepanova M, Goodman Z, Younossi Z. HLA-A11 Gene Loci Is Strongly Predictive of Susceptibility to Severe Hepatic Steatosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): 383 The American Journal of Gastroenterology. 107. DOI: 10.14309/00000434-201210001-00383  0.486
2012 Birerdinc A, Estep JM, Mehta R, Wang L, Afendy A, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Tu1816 Multi-System Analysis of the Inflammatory-Immunomodulatory-Obesity Axis in Non-Alcoholic Liver Disease (NAFLD) Gastroenterology. 142: S-1024. DOI: 10.1016/S0016-5085(12)63962-6  0.825
2011 Younossi ZM, Limongi D, Stepanova M, Pierobon M, Afendy A, Mehta R, Baranova A, Liotta L, Petricoin E. Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV). Journal of Proteome Research. 10: 774-9. PMID 21204552 DOI: 10.1021/Pr100923U  0.484
2011 Younossi Z, Baranova A, Abawi M, Afendy A, Mehta R, Stepanova M, Goodman Z, Chandhoke V, Birerdinc A. Vitamin D Level in Non-Alcoholic Fatty Liver Disease (NAFLD) Patients Remains Deficient Despite Multivitamin Supplementation American Journal of Gastroenterology. 106: S120. DOI: 10.14309/00000434-201110002-00301  0.742
2011 Mehta R, Birerdinc A, Wang L, Afendy A, Stepanova M, Elariny HA, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Gastric Gene Expression of Inflammatory Cytokines in Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Gastroenterology. 140: S-985. DOI: 10.1016/S0016-5085(11)64083-3  0.772
2011 Birerdinc A, Mehta R, Wang L, Afendy A, Stepanova M, Elariny HA, Moazzez AH, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of Energy Metabolism Related Genes in the Gastric Tissue of Obese Patients Gastroenterology. 140: S-117. DOI: 10.1016/S0016-5085(11)60474-5  0.73
2010 Mehta R, Birerdinc A, Hossain N, Afendy A, Chandhoke V, Younossi Z, Baranova A. Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples. Bmc Molecular Biology. 11: 39. PMID 20492695 DOI: 10.1186/1471-2199-11-39  0.741
2010 Alhussain R, Mehta R, Birerdinc A, Hossain N, Baraki Y, Elariny H, Chandhoke V, Baranova A, Younossi Z. Profiling and Validation of Reference Genes in the Gastric Tissue of Morbidly Obese Patients American Journal of Gastroenterology. 105: S37. DOI: 10.14309/00000434-201010001-00098  0.732
2010 Mehta R, Birerdinc A, Hossain N, Moazez AH, Chandhoke V, Baranova A, Younossi ZM. W1853 Profiling and Validation of Reference Genes in the Visceral Adipose Tissue (Vat) Gastroenterology. 138: S-753-S-754. DOI: 10.1016/S0016-5085(10)63473-7  0.704
2010 Birerdinc A, Mehta R, Hossain N, Baraki Y, Elariny HA, Baranova A, Chandhoke V, Younossi ZM. W1852 Differential Gene Expression Profiling of Brown Adipose Tissue (Bat) Specific Genes in Visceral Adipose Tissue of Lean and Obese Individuals Gastroenterology. 138: S-753. DOI: 10.1016/S0016-5085(10)63472-5  0.732
Show low-probability matches.